Plancorp LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,446
Closed -$433K 184
2020
Q1
$433K Buy
2,446
+17
+0.7% +$3.2K 0.17% 95
2019
Q4
$464K Hold
2,429
0.14% 113
2019
Q3
$409K Buy
2,429
+19
+0.8% +$3.1K 0.16% 107
2019
Q2
$404K Buy
2,410
+32
+1% +$4.43K 0.16% 105
2019
Q1
$348K Sell
2,378
-197
-8% -$28.6K 0.13% 123
2018
Q4
$344K Buy
2,575
+6
+0.2% +$984 0.16% 108
2018
Q3
$489K Buy
2,569
+13
+0.5% +$2.39K 0.19% 99
2018
Q2
$426K Sell
2,556
-141
-5% -$22.6K 0.17% 104
2018
Q1
$454K Buy
2,697
+141
+6% +$23.7K 0.15% 95
2017
Q4
$418K Hold
2,556
0.14% 105
2017
Q3
$524K Sell
2,556
-26
-1% -$6.05K 0.15% 88
2017
Q2
$628K Buy
2,582
+26
+1% +$6.11K 0.19% 83
2017
Q1
$611K Hold
2,556
0.18% 85
2016
Q4
$536K Buy
+2,556
New +$529K 0.15% 89
2016
Q1
Sell
-1,800
Closed -$563K 83
2015
Q4
$563K Hold
1,800
0.67% 37
2015
Q3
$489K Hold
1,800
0.44% 49
2015
Q2
$546K Hold
1,800
0.51% 38
2015
Q1
$536K Buy
+1,800
New +$513K 0.53% 48

Other funds holding AGN

Plancorp LLC's AGN Position: Q2 2020 in Review

Plancorp LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,446 shares — an estimated $433K sold.

Plancorp LLC first reported a position in AGN in Q1 2015 and held it in 18 quarters. The position peaked at $628K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Plancorp LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Plancorp LLC sold 2,446 Allergan plc shares in Q2 2020, an estimated $433K.
  • Plancorp LLC first reported a position in Allergan plc in Q1 2015 and held it in 18 quarters.
  • Plancorp LLC's Allergan plc position peaked at $628K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Plancorp LLC's 13F filing for Q2 2020, filed 11 Aug 2020.